E for L Aim Public Company Limited
E for L Aim Public Company Limited, together with its subsidiaries, engages in the distribution of medical devices and equipment in Thailand. The company offers clinical hematology, microscopy, chemistry, immunology, and microbiology related products. It also provides various equipment for medical devices. In addition, the company offers educational, clinical and laboratory microscopes, and scien… Read more
E for L Aim Public Company Limited (EFORL) - Net Assets
Latest net assets as of September 2025: ฿576.25 Million THB
Based on the latest financial reports, E for L Aim Public Company Limited (EFORL) has net assets worth ฿576.25 Million THB as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿1.29 Billion) and total liabilities (฿712.91 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ฿576.25 Million |
| % of Total Assets | 44.7% |
| Annual Growth Rate | 7.21% |
| 5-Year Change | N/A |
| 10-Year Change | -81.84% |
| Growth Volatility | 554.9 |
E for L Aim Public Company Limited - Net Assets Trend (2007–2024)
This chart illustrates how E for L Aim Public Company Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for E for L Aim Public Company Limited (2007–2024)
The table below shows the annual net assets of E for L Aim Public Company Limited from 2007 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ฿544.31 Million | +3.75% |
| 2023-12-31 | ฿524.62 Million | +3.59% |
| 2022-12-31 | ฿506.42 Million | +28.90% |
| 2021-12-31 | ฿392.89 Million | +152.98% |
| 2020-12-31 | ฿-741.64 Million | -609.20% |
| 2019-12-31 | ฿-104.57 Million | -137.79% |
| 2018-12-31 | ฿276.72 Million | +389.56% |
| 2017-12-31 | ฿-95.56 Million | -104.81% |
| 2016-12-31 | ฿1.99 Billion | -33.69% |
| 2015-12-31 | ฿3.00 Billion | +53.81% |
| 2014-12-31 | ฿1.95 Billion | +179.35% |
| 2013-12-31 | ฿697.78 Million | +2127.96% |
| 2012-12-31 | ฿31.32 Million | -67.63% |
| 2011-12-31 | ฿96.75 Million | -34.94% |
| 2010-12-31 | ฿148.70 Million | -45.57% |
| 2009-12-31 | ฿273.21 Million | +2.72% |
| 2008-12-31 | ฿265.97 Million | +59.71% |
| 2007-12-31 | ฿166.53 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to E for L Aim Public Company Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 12550.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ฿3.00 Billion | 550.94% |
| Other Comprehensive Income | ฿37.00 Million | 6.80% |
| Total Equity | ฿544.31 Million | 100.00% |
E for L Aim Public Company Limited Competitors by Market Cap
The table below lists competitors of E for L Aim Public Company Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Innovative Designs
PINK:IVDN
|
$13.48 Million |
|
TLGUF
PINK:TLGUF
|
$13.48 Million |
|
TNT Group JSC
VN:TNT
|
$13.48 Million |
|
Xinyuan Real Estate Co Ltd
NYSE:XIN
|
$13.49 Million |
|
Triunfo Participações e Investimentos S.A
SA:TPIS3
|
$13.47 Million |
|
Genomtec S.A.
WAR:GMT
|
$13.47 Million |
|
Lanson BCC SA
PA:ALLAN
|
$13.47 Million |
|
Asefa Public Company Limited
BK:ASEFA
|
$13.46 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in E for L Aim Public Company Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 524,619,000 to 544,312,000, a change of 19,693,000 (3.8%).
- Net income of 19,693,000 contributed positively to equity growth.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ฿19.69 Million | +3.62% |
| Total Change | ฿- | 3.75% |
Book Value vs Market Value Analysis
This analysis compares E for L Aim Public Company Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.03x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.12x to 1.03x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | ฿1.18 | ฿0.14 | x |
| 2008-12-31 | ฿1.39 | ฿0.14 | x |
| 2009-12-31 | ฿0.98 | ฿0.14 | x |
| 2010-12-31 | ฿0.53 | ฿0.14 | x |
| 2011-12-31 | ฿0.35 | ฿0.14 | x |
| 2012-12-31 | ฿0.11 | ฿0.14 | x |
| 2013-12-31 | ฿1.16 | ฿0.14 | x |
| 2014-12-31 | ฿0.70 | ฿0.14 | x |
| 2015-12-31 | ฿1.42 | ฿0.14 | x |
| 2016-12-31 | ฿0.90 | ฿0.14 | x |
| 2017-12-31 | ฿0.09 | ฿0.14 | x |
| 2018-12-31 | ฿0.19 | ฿0.14 | x |
| 2019-12-31 | ฿0.10 | ฿0.14 | x |
| 2020-12-31 | ฿0.23 | ฿0.14 | x |
| 2021-12-31 | ฿0.11 | ฿0.14 | x |
| 2022-12-31 | ฿0.13 | ฿0.14 | x |
| 2023-12-31 | ฿0.13 | ฿0.14 | x |
| 2024-12-31 | ฿0.14 | ฿0.14 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently E for L Aim Public Company Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.62%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.47%
- • Asset Turnover: 0.95x
- • Equity Multiplier: 2.58x
- Recent ROE (3.62%) is above the historical average (-73.29%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 14.03% | 17.21% | 0.57x | 1.43x | ฿6.72 Million |
| 2008 | 18.59% | 22.44% | 0.70x | 1.18x | ฿22.84 Million |
| 2009 | -20.12% | -27.53% | 0.64x | 1.15x | ฿-82.28 Million |
| 2010 | -83.73% | -80.13% | 0.81x | 1.29x | ฿-139.38 Million |
| 2011 | -52.98% | -26.61% | 1.20x | 1.66x | ฿-60.93 Million |
| 2012 | -208.91% | -75.03% | 1.43x | 1.94x | ฿-68.56 Million |
| 2013 | 3.79% | 15.49% | 0.20x | 1.21x | ฿-43.32 Million |
| 2014 | 25.65% | 16.60% | 0.20x | 7.85x | ฿146.88 Million |
| 2015 | 16.12% | 4.67% | 0.62x | 5.60x | ฿79.88 Million |
| 2016 | -63.82% | -16.73% | 0.54x | 7.01x | ฿-710.72 Million |
| 2017 | -885.07% | -47.02% | 0.64x | 29.57x | ฿-1.18 Billion |
| 2018 | -37.59% | -8.07% | 0.64x | 7.27x | ฿-210.55 Million |
| 2019 | -182.20% | -30.74% | 0.79x | 7.54x | ฿-623.00 Million |
| 2020 | -86.31% | -38.01% | 1.07x | 2.12x | ฿-706.92 Million |
| 2021 | 206.68% | 37.50% | 1.29x | 4.27x | ฿772.74 Million |
| 2022 | 10.47% | 3.55% | 0.97x | 3.05x | ฿2.40 Million |
| 2023 | 2.56% | 1.03% | 0.96x | 2.61x | ฿-39.03 Million |
| 2024 | 3.62% | 1.47% | 0.95x | 2.58x | ฿-34.74 Million |
Industry Comparison
This section compares E for L Aim Public Company Limited's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $120,386,035
- Average return on equity (ROE) among peers: 43.04%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| E for L Aim Public Company Limited (EFORL) | ฿576.25 Million | 14.03% | 1.24x | $13.47 Million |
| Healthlead Public Company Limited (HL) | $124.97 Million | 41.67% | 2.19x | $14.54 Million |
| SEI (SEI) | $28.36 Million | 62.98% | 8.85x | $3.29 Million |
| SaintMed Public Company Limited (SMD) | $135.64 Million | 40.21% | 2.49x | $11.69 Million |
| Techno Medical Public Company Limited (TM) | $222.40 Million | 20.33% | 1.97x | $2.95 Million |
| Winnergy Medical Public Company Limited (WINMED) | $90.56 Million | 49.99% | 2.66x | $3.06 Million |